Rebif 44mcg Injection
By Rebif
Rx
1 Injection in a Vial

Composition
Interferon Beta-1A(44mcg)

Manufacturer - Merck Ltd
L-2, J.R. Complex, Gate No. 4, Village Mandoli, Delhi-110 093, India

Expires on or after
August, 2025

liver
When using Rebif 44mcg Injection, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Rebif 44mcg Injection. It is crucial to consult your doctor regarding the use of this medication to ensure your safety.

kidney
Rebif 44mcg Injection requires caution if you have severe kidney disease. Your doctor may need to adjust the dosage. Make sure to consult with your doctor about using this medication.

alcohol
It is not recommended to consume alcohol while using Rebif 44mcg Injection.

driving
Rebif 44mcg Injection can reduce alertness, impact vision, induce drowsiness, and dizziness. Avoid driving if experiencing these effects for safety.

pregnancy
Rebif 44mcg Injection is not recommended during pregnancy due to potential harm. Limited human studies and animal studies indicate risks to the baby. Consult your doctor for an evaluation of benefits and risks before usage.

breastfeeding
Rebif 44mcg Injection is likely safe for use while breastfeeding. Limited data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | Amino Acids, Peptides, and Analogues |
Therapeutic Class | - |
Action Class | Interferons |
₹6030
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025